Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4.78x is 83% above its 5-year average of -28.77x, near the high end of its 5-year range (-94.66x–-3.75x).
0.84% above its 12-month average of -4.82x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -4.55x.
INTEREST COVERAGE RATIO
-4.78x
INTEREST COVERAGE RATIO AVG TTM
-4.82x
INTEREST COVERAGE RATIO AVG 3Y
-4.77x
INTEREST COVERAGE RATIO AVG 5Y
-28.77x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.84%
CURRENT VS 3Y AVG
-0.22%
CURRENT VS 5Y AVG
+83.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 516 covered companies
CURRENT VS SECTOR MEDIAN
+25.02%
vs the sector median at left
Outset Medical, Inc.
Market Cap
$76.56M
Interest Coverage Ratio
-4.78x
TTM Avg
-4.82x
3Y Avg
-4.77x
5Y Avg
-28.77x
Market Cap
$75.75M
Interest Coverage Ratio
-1.08x
TTM Avg
0.90x
3Y Avg
0.90x
5Y Avg
0.90x
Market Cap
$77.08M
Interest Coverage Ratio
-17.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.91M
Interest Coverage Ratio
-4056.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.09M
Interest Coverage Ratio
-23.23x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$77.38M
Interest Coverage Ratio
N/A
TTM Avg
273.61x
3Y Avg
273.61x
5Y Avg
273.61x
Market Cap
$80.47M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outset Medical, Inc. (OM) | $76.56M | -4.78x | -4.82x | -4.77x | -28.77x |
| Hyperfine, Inc. (HYPR)vs › | $76.48M | N/A | N/A | N/A | N/A |
| SkinHealth Systems Inc. (SKIN)vs › | $75.75M | -1.08x | 0.90x | 0.90x | 0.90x |
| Pulmonx Corporation (LUNG)vs › | $77.08M | -17.01x | N/A | N/A | N/A |
| Sera Prognostics, Inc. (SERA)vs › | $77.91M | -4056.00x | N/A | N/A | N/A |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $79.09M | -23.23x | N/A | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $77.38M | N/A | 273.61x | 273.61x | 273.61x |
| Nutriband Inc. (NTRB)vs › | $81.14M | -369.11x | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.47M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $80.84M | -107.89x | N/A | N/A | N/A |
Interest Coverage
-4.8x
Debt/Equity
1.08
Current Ratio
5.19
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4.55x |
| 2026-03-31 | -5.02x |
| 2025-12-31 | -5.12x |
| 2025-09-30 | -4.55x |
| 2025-06-30 | -4.85x |
| 2025-03-31 | -4.61x |
| 2024-12-31 | -3.75x |
| 2024-09-30 | -3.93x |
| 2024-06-30 | -5.12x |
| 2024-03-31 | -6.18x |
| 2023-12-31 | -10.93x |
| 2023-09-30 | -14.15x |
| 2023-06-30 | -14.01x |
| 2023-03-31 | -14.78x |
| 2022-12-31 | -19.00x |
| 2022-09-30 | -72.31x |
| 2022-06-30 | -90.90x |
| 2022-03-31 | -86.43x |
| 2021-12-31 | -94.66x |
| 2021-09-30 | -69.93x |
| 2021-06-30 | -69.39x |
| 2021-03-31 | -70.32x |
| 2020-12-31 | -73.87x |
| 2020-09-30 | -94.51x |
| 2020-06-30 | -24.14x |
| 2020-03-31 | -20.19x |
| 2019-12-31 | -18.21x |
| 2019-09-30 | -17.62x |
